Company: BCDRF
Filing Date: 2025-03-03
Form Type: 6-K
Source: 0000891478-25-000057
Chunk: 24

Company: Banco Santander, S.A.
Filing Date: 2025-03-03
Form: 6-K
Chunk 24
---
   |     |                                                       -16,344 |   |     |                                                 -16,255 |                           |     |                                   — |   |     |                                — |   |     |                                                                        — |   |     |        — |   |     |    -16,255 |
| 10 |     | Total liabilities                                                                                                                                                 |     |   |     |                                                    -1,729,754 |   |     |                                              -1,713,006 |                           |     |                                -710 |   |     |                         -121,032 |   |     |                                                                        — |   |     | -188,865 |   |     | -1,518,661 |

2024 Pillar 3 Disclosures Report 23

| Index |     | Introduction |     | Capital |     | Risks |     | Risk taker's remunerations |     | Appendices |

The difference in total assets between the public and the reserved scopes is not material (-EUR 16,794 Bn) and corresponds to the exclusion of non financial institutions (-EUR 26,088 Bn) and the inclusion of jointly controlled (+EUR 13,572 Bn) and intra/group entities (-EUR 4,278 Bn).

In addition, the sum of the carrying amounts of certain items is greater than the carrying amounts under the scope of prudential consolidation, as the financial assets held for trading and the financial assets at fair value through profit or

loss are subject to the capital requirements of more than one risk category under the regulatory scope.

The main differences between the carrying amounts in the financial statements and the exposures for prudential purposes are shown below:

| Table 3.LI2 - Main sources of differences between regulatory exposure amounts and carrying values in financial statements |     |                                                                                                    |     |       |     |                       |                   |     |               |   |     |                          |   |     |                       |   |     |          |
| EUR million                                                                                                               |     |                                                                                                    |     |       |     |                       |                   |     |               |   |     |                          |   |     |                       |   |     |          |
|                                                                                                                           |     |                                                                                                    |     |       |     |                       |                   |     |               |   |     |                          |   |     |                       |   |     |     2024 |
|                                                                                                                           |     |                                                                                                    |     | a     |     |                       | b                 |     |               | c